Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Inquire about the patients medication use focusing on drugs or agents that could potentially cause bleeding or impair coagulation such as anticoagulants, non-steroidal anti-inflammatory agents, and any other antiplatelet agent the patient may have used in the past
has grown 49% over six months, from 90,500 monthly searches in September 2025 to over 135,000 by February 2026
They could also use lab valuesnot just HbA1c, but also lipids, glucose, liver function, and kidney functionto identify patients who are at high risk of cardiometabolic conditions and who might therefore benefit from GLP-1 drugs
doi: 10.3389/fendo.2026.1858420 Received 17 April 2026 Revised 19 June 2026 Accepted 19 June 2026 Published 06 July 2026 Volume 17 - 2026 Edited by Srinivas Mummidi, Texas A&M University San Antonio, United States Reviewed by Raylene A
US$ 24.78
US$ 20.78
US$ 21.23
US$ 29.68
US$ 26.15
